$1.04
-0.0200 (-1.89%)
At Close: Jun 03, 2026
Cannabis Watch: Canopy Growth and Aurora Cannabis are expected to generate less red ink when they report earnings this week
02:39pm, Tuesday, 08'th Feb 2022
Aurora Cannabis Inc. and Canopy Growth Corp. are expected to remain in the red but trim their losses when they release financial results later this week, as they face a sluggish legal cannabis market
Beyond Flower: The Future of Cannabis?
02:13pm, Tuesday, 08'th Feb 2022 Benzinga
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The success of the cannabis industry – valued at $20.47 billion in 2020 by Fortune Business Insights and expected to grow to $197.74 billion by 2028 – has brought a slew of players looking to capitalize on its rapid growth, and to stay competitive, established companies must continue to innovate. Industry leader Canopy Growth Corp. (TSX: WEED) (NASDAQ: CGC ) has long held innovation at the heart of its operations. The consumer-centric company believes that its success has, in large part, come from its faithful quest to deliver what its customers desire. As consumer taste matures and shifts, Canopy looks to lead the industry forward. Perhaps the most significant of these consumer shifts in preference is the desire for alternatives to flower and the benefits of CBD. Benzinga sat down with Canopy interim Chief Product Officer, Tara Rozalowsky, to discuss the company’s vision for the future of cannabis and the products that will be at the center of the industry. “Flower is still a large percentage of the cannabis business worldwide.
Canopy Growth, Aurora Earnings Likely To Set The Pace For Cannabis Sector Results
01:01pm, Tuesday, 08'th Feb 2022 Investing.com
https://www.investing.com/analysis/canopy-growth-aurora-earnings-likely-to-set-the-pace-for-cannabis-sector-results-200617384
Canopy Growth: Insight Into Upcoming Q3-2022 Earnings
07:00am, Tuesday, 08'th Feb 2022
Canopy Growth: Insight Into Upcoming Q3-2022 Earnings
Canopy Growth Corporation (NASDAQ: CGC) Could Pass $22.50 In One Year Stock Forecast
07:00pm, Monday, 07'th Feb 2022 Stocks Register
Canopy Growth Corporation (NASDAQ:CGC) price is hovering higher on Monday, February 07, jumping 3.95% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Earnings Previews: Cameco, Canopy Growth, CVS Health
06:37pm, Monday, 07'th Feb 2022 24/7 Wall street
Before markets open Wednesday we will hear earnings results from a key uranium miner, a struggling marijuana grower and a pharmacy/health care services giant.
Earnings Previews: Cameco, Canopy Growth, CVS Health
01:37pm, Monday, 07'th Feb 2022
Merger Monday was living up to its name, as Frontier Airlines has announced a merger with Spirit Airlines aimed at creating the lowest-cost U.S.
1 Red Flag for Canopy Growth in 2022, and 1 Green Flag
06:49am, Monday, 07'th Feb 2022
Massive rights agreements should set the tone going forward but not everyone is convinced just yet
2 Canadian marijuana stocks to keep a close eye on
05:41pm, Saturday, 05'th Feb 2022
Marijuana stocks in Canada continue to tumble as fierce competition prevents the big brands on U.S exchanges from capturing a larger share of the Canadian market. So, which Canadian marijuana stocks s
These Pot Stocks Went Wild This Week
04:05pm, Friday, 04'th Feb 2022
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we k
2 Canadian Marijuana Stocks To Watch Right Now
10:14am, Friday, 04'th Feb 2022
Canadian Marijuana Stocks For Your 2022 Watchlist The post 2 Canadian Marijuana Stocks To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industr
Cannabis Watch: Cannabis companies pivot to debt to raise capital as stock prices lag
02:49pm, Thursday, 03'rd Feb 2022
Columbia Care Inc. and Trulieve Cannabis Corp. announced separate debt deals in recent days as cannabis companies turn away from issuing stock to raise capital in the face of weak share prices.
What's in Store for Canopy Growth (CGC) in Q3 Earnings?
10:45am, Thursday, 03'rd Feb 2022
New product launches across the CBD product portfolio and robust demand for legal cannabis products are likely to drive Canopy Growth's (CGC) Q3 top line.
Why Marijuana Stocks Hit a Pot-Hole Today
03:25pm, Wednesday, 02'nd Feb 2022
Marijuana banking legislation advances in the House. But will it make a difference?
Chart Wars: Between Tilray And Canopy Growth, Which Cannabis Stock Could Slam Shorts Harder?
04:37pm, Tuesday, 01'st Feb 2022 Benzinga
Canopy Growth Corporation (NASDAQ: CGC ) and Tilray, Inc (NASDAQ: TLRY ) soared 10.59% and 8.76%, respectively, on Monday. The overall sector has been all but demolished since the high times of 2018, when Canada legalized cannabis at the federal level, and the beginning of 2021, when President Joe Bidens inauguration led many to believe federal legalization in the U.S. may be on the horizon. Canopy Growth Corporation has plummeted 86% from its Oct. 16, 2018 all-time high of $59.25, while Tilray has plunged about 98% from its Sept. 19, 2018 all-time high of $300. Although the stocks shot up again in February 2021, with Canopy Growth reaching a high of $56.50 and Tilray soaring up to the $67 level on Feb. 10, the sector has failed to sustain any long-term bull cycle. If neither a continued bounce nor bull cycle takes place, the stocks are beginning to show some characteristics that could make them candidates for a short squeeze. Canopy Growth comes in as a better candidate for a squeeze, with 18.13% of its float held short compared to Tilray, which has 13.16% of its float held short.
Sign In
Buy CGC